Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Immunisation at Birth for Allergy and Infection (MIS BAIR)
NCT01906853Phase 3Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2013
- Primary completion
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bcg vaccine in allergy, Eczema, respiratory tract infection (RTI), asthma, food allergy, sponsored by Murdoch Children's Research Institute. Started Jul 2013; status: completed.
02
Drugs
bcg vaccine
03
Conditions
allergyEczemarespiratory tract infection (RTI)asthmafood allergy
Beyond the preview
Go deeper on NCT01906853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906853.